One of the mechanisms implicated as central to ketamine’s antidepressant mechanisms, is a rapid elevation of the growth factor brain-derived neurotrophic factor (BDNF), also implicated in the pathophysiology of depression and response to conventional antidepressants (Björkholm and Monteggia, 2016). Here, BDNF is linked to depressive disorder.